论文部分内容阅读
目的:观察非洛地平缓释片联合福辛普利片治疗老年单纯收缩期高血压(ISH)的疗效。方法:选取120例单纯收缩期老年高血压患者,分别用非洛地平缓释片(A组)、福辛普利片(B组)、非洛地平缓释片和福辛普利片联合(C组)治疗12周,观察治疗效果。结果:治疗后,C组的疗效要高于A组和B组,C组可显著降低老年单纯收缩期高血压患者的收缩压(SBP)(P<0.05);而三组的舒张压(DBP)水平无明显改变(P>0.05);3组未见严重不良反应。结论:非洛地平缓释片联合福辛普利片在控制老年单纯收缩期高血压的疗效明显优于单种用药。
Objective: To observe the efficacy of felodipine sustained-release tablets combined with fosinopril tablets in the treatment of elderly isolated systolic hypertension (ISH). Methods: A total of 120 patients with isolated systolic hypertension were selected and treated with felodipine (A), fosinopril (B), felodipine and fosinopril C group) for 12 weeks, observe the effect of treatment. Results: After treatment, the efficacy of group C was higher than that of group A and group B, and group C significantly reduced systolic blood pressure (SBP) in elderly patients with isolated systolic hypertension (P <0.05); while the DBP ) Had no significant change (P> 0.05). No serious adverse reactions were observed in the three groups. Conclusion: The efficacy of felodipine combined with fosinopril in controlling elderly patients with isolated systolic hypertension is superior to that of single drug.